Business Description
Precision BioSciences Inc
NAICS : 325412
SIC : 2834
ISIN : US74019P1084
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.01 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | 1.26 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.6 | |||||
Beneish M-Score | 9.71 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.2 | |||||
3-Year EBITDA Growth Rate | 47.4 | |||||
3-Year EPS without NRI Growth Rate | 43.6 | |||||
3-Year FCF Growth Rate | 25 | |||||
3-Year Book Growth Rate | -43.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -31.42 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.82 | |||||
9-Day RSI | 60.44 | |||||
14-Day RSI | 58.26 | |||||
6-1 Month Momentum % | -24.02 | |||||
12-1 Month Momentum % | -34.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.37 | |||||
Quick Ratio | 4.37 | |||||
Cash Ratio | 3.75 | |||||
Days Sales Outstanding | 4.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.3 | |||||
Shareholder Yield % | -61.15 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -8.32 | |||||
Net Margin % | 19.36 | |||||
FCF Margin % | -75.23 | |||||
ROE % | 43.76 | |||||
ROA % | 9.91 | |||||
ROIC % | -11.04 | |||||
3-Year ROIIC % | -456.5 | |||||
ROC (Joel Greenblatt) % | 123.81 | |||||
ROCE % | 14.28 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.45 | |||||
PS Ratio | 0.66 | |||||
PB Ratio | 0.99 | |||||
Price-to-Tangible-Book | 0.99 | |||||
EV-to-EBIT | -0.98 | |||||
EV-to-EBITDA | -0.72 | |||||
EV-to-Forward-EBITDA | -0.09 | |||||
EV-to-Revenue | -0.2 | |||||
EV-to-Forward-Revenue | 0.1 | |||||
EV-to-FCF | 0.27 | |||||
Price-to-Net-Current-Asset-Value | 1.4 | |||||
Price-to-Net-Cash | 2.27 | |||||
Earnings Yield (Greenblatt) % | -102.04 | |||||
FCF Yield % | -87.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Precision BioSciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 81.279 | ||
EPS (TTM) (€) | 0.303 | ||
Beta | 0 | ||
Volatility % | 47.09 | ||
14-Day RSI | 58.26 | ||
14-Day ATR (€) | 0.29155 | ||
20-Day SMA (€) | 8.7075 | ||
12-1 Month Momentum % | -34.76 | ||
52-Week Range (€) | 7.6 - 13.3 | ||
Shares Outstanding (Mil) | 7.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Precision BioSciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Precision BioSciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Precision BioSciences Inc Frequently Asked Questions
What is Precision BioSciences Inc(STU:PBS0)'s stock price today?
When is next earnings date of Precision BioSciences Inc(STU:PBS0)?
Does Precision BioSciences Inc(STU:PBS0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |